Diva FSH- 150 HP Injection

Urofollitropin 150IU Injection contains Urofollitropin, a highly purified follicle-stimulating hormone (FSH) obtained from the urine of postmenopausal women. It is used in the treatment of infertility by stimulating the growth and development of ovarian follicles in women who have ovulation disorders. It may also be used as part of assisted reproductive technology (ART) procedures such as in vitro fertilization (IVF).

Before starting treatment, inform your doctor if you have a history of ovarian cysts, thyroid disorders, adrenal gland disorders, or unexplained vaginal bleeding. Women who are pregnant or breastfeeding should not use this medication. Regular monitoring with ultrasound scans and hormone tests is recommended during treatment to assess ovarian response and reduce the risk of complications.

Brand Name: Diva FSH-150 HP

Composition: Urofollitropin 150 IU

Mechanism of Action:

Urofollitropin is a purified follicle-stimulating hormone (FSH) that stimulates the growth and maturation of ovarian follicles in women. In men, FSH supports spermatogenesis by acting on the Sertoli cells of the testes. By promoting follicular development and ovulation, Urofollitropin helps improve fertility outcomes in appropriately selected patients.

Uses:

• Female infertility due to ovulation disorders
• In vitro fertilization (IVF) procedures
• Intracytoplasmic sperm injection (ICSI) cycles
• Male infertility associated with hypogonadotropic hypogonadism

Dosage and Administration:

Urofollitropin Injection is administered under the supervision of a fertility specialist. The dosage and duration of treatment depend on the patient's age, medical condition, hormone levels, and response to therapy.

The injection is usually administered subcutaneously or intramuscularly. During treatment, regular ultrasound examinations and hormone monitoring may be required to evaluate follicular development and adjust the dose accordingly.

Side Effects:

• Headache
• Nausea
• Abdominal pain
• Bloating
• Injection site pain or redness
• Ovarian enlargement
• Breast tenderness
• Pelvic discomfort
• Ovarian Hyperstimulation Syndrome
• Multiple pregnancy

Safety Advice:

Kidney  

Patients with a history of renal impairment should use Urofollitropin with caution since it may cause other kidney related problems. Kindly speak with your healthcare provider.

Liver  

Patients with a history of liver disease should use Urofollitropin with caution since it may cause other liver related problems. Kindly speak with your healthcare provider.

Pregnancy  

Pregnant women should not take Urofollitropin as they may harm the fetus. Kindly speak with your healthcare provider.

Breast Feeding  

It's unknown if the Urofollitropin tablet affects your breast milk or if it gets into your breast milk.  Kindly speak with your healthcare provider. 

Alcohol  

It is advised that you stop drinking while using Urofollitropin in order to prevent unwanted side effects. Kindly speak with your healthcare provider.

How to Use this Medication?

Urofollitropin should be administered exactly as prescribed by your fertility specialist. The injection is generally given daily for a specified treatment period depending on the fertility protocol.

Follow all instructions regarding injection preparation, administration, and storage. Do not alter the prescribed dose without consulting your doctor. Regular monitoring through ultrasound scans and blood hormone tests is essential during treatment.

If you miss a dose, contact your fertility specialist immediately for guidance. Do not take a double dose to compensate for a missed dose.

References:

1. Howles CM. Role of FSH in ovarian follicular growth and development. Human Reproduction Update. 2000;6(2):141-148.
2. Fauser BCJM, Devroey P. Reproductive biology and IVF. Lancet. 2011;378(9807):2090-2102.
3. Fritz MA, Speroff L. Clinical Gynecologic Endocrinology and Infertility. 8th Edition. Lippincott Williams & Wilkins.
4. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 13th Edition.
5. European Society of Human Reproduction and Embryology (ESHRE) Guidelines on Ovarian Stimulation.

Disclaimer:

The main goal of Apothecare Specialities Pvt Ltd is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Specialities Pvt Ltd, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.

Marketer Details

Name: Bharat Serums and Vaccines Limited
Address: 301, 3rd Floor, Hubtown Solaris, N.S. Phadke Marg, Andheri (East), Mumbai – 400069, Maharashtra, India
Country of Origin: India

Frequently Asked Questions (FAQs):

1. What is Urofollitropin Injection?
Urofollitropin is a fertility medication containing follicle-stimulating hormone (FSH) that helps stimulate ovarian follicle growth in women undergoing fertility treatment.

2. How does Urofollitropin work?
It promotes the development and maturation of ovarian follicles, increasing the likelihood of ovulation and successful fertility treatment.

3. What conditions is Urofollitropin used for?
It is used for female infertility, ovulation induction, controlled ovarian stimulation, IVF, and certain cases of male infertility.

4. How is Urofollitropin administered?
It is administered as a subcutaneous or intramuscular injection under medical supervision.

5. How often is the injection given?
The frequency and duration depend on the fertility treatment protocol prescribed by the specialist.

6. What are the common side effects?
Common side effects include headache, abdominal pain, bloating, nausea, and injection site reactions.

7. Can Urofollitropin cause ovarian hyperstimulation syndrome (OHSS)?
Yes. OHSS is a known complication and requires close monitoring by a fertility specialist.

8. Is monitoring necessary during treatment?
Yes. Ultrasound scans and hormone tests are essential to evaluate ovarian response and reduce treatment risks.

9. Can Urofollitropin increase the chance of multiple pregnancies?
Yes. Fertility treatment with Urofollitropin may increase the likelihood of twins or multiple pregnancies.

10. Can I use Urofollitropin during pregnancy?
No. Urofollitropin is not indicated for use during pregnancy.